Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial ...

Daiichi Sankyo seeks Japanese approval for Enhertu to treat patients with HER2 positive metastatic solid tumours: Tokyo Friday, April 25, 2025, 09:00 Hrs [IST] Daiichi Sankyo has ...

Amid heightened concerns about U.S. aviation infrastructure, a crop of startups are bullish that they will disrupt the travel ...

McLaren Minerals has put a bow on a 6000m air core drilling campaign at its flagship McLaren titanium project in WA’s Eucla ...

Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

Pleasanton, California - Boster Bio Technology unlocks insights into cancer and neurological disorders with high-quality ...

AZ's head of oncology and haematology, Dave Fredrickson, said the approval "highlights the importance of testing metastatic breast cancer tumours for detectable staining with a standard IHC test ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Breast cancer classed as HER2-positive - defined as an immunohistochemical (IHC) score of three or more – accounts for somewhere between 20% to 25% of all patients with the disease. However ...

If the European Commission approves this treatment, it'll be the first HER2-targeted agent for HER2-positive biliary tract cancer available to patients in the EU.

ISLAMABAD: Pakistan Tehreek-e-Insaf (PTI) Chairman Barrister Gohar Ali Khan, Friday, confirmed a meeting of the PTI delegation with Acting Chief Justice of the Islamabad High Court (IHC), Justice ...